Kinase Inhibitors (Ibrutinib Or Idelalisib) In The Management Of Chronic Lymphocytic Leukemia-Associated Autoimmune Cytopenia: A Retrospective Study Of The French Innovative Leukemia Organization (Filo)

BLOOD(2018)

引用 1|浏览13
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要